Merus B.V., a biopharmaceutical company focusing on innovative human antibody therapeutics, has presented preclinical data on its antibody MCLA-117 at the Annual 18th Congress of the EHA 2013 in Stockholm.
http://www.drugs.com/news/merus-presents-preclinical-data-novel-bispecific-antibody-mcla-117-eha-2013-45230.html?
http://www.drugs.com/news/merus-presents-preclinical-data-novel-bispecific-antibody-mcla-117-eha-2013-45230.html?
No comments:
Post a Comment